Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 October 2023 | Story VALENTINO NDABA | Photo PEXELS
mental health during exam season
Ensuring good mental wellbeing is very important ahead of and during exam periods.

As the exam season approaches, students across the board face large amounts of extra stress and anxiety. Examinations carry tremendous weight in determining students’ prospects, making it a time of immense pressure.

The Department of Student Counselling and Development (SCD) at the University of the Free State (UFS) has been a steadfast source of support to its students since the SCD's establishment in 1977. SCD offers an array of free services to all registered students across the Bloemfontein, South, and Qwaqwa campuses, regardless of their level of study, whether undergraduate or postgraduate.

SCD's primary objective is to cultivate a deep understanding of holistic mental health within the UFS community and address wellness concerns effectively. This mission is pursued through individual therapy sessions, group sessions, workshops, developmental programmes, and career counselling. The department also plays a pivotal role in knowledge production, evidence-based interventions, and mental health innovations, contributing significantly to students’ mental wellbeing.

Academic wellbeing 

To coincide with the exam season and World Mental Health Awareness Month in October, SCD offers academic-wellbeing resources tailored to students to help them become ‘Wellbeing Warriors’. These resources include guides such as 'Taming Test and Exam Anxiety’, 'I Don't Know How to Study’, and 'Where Is My Time Going?'. These resources are designed to equip students with the tools they need to manage the stress and anxiety that often accompany exams.

Taming Test and Exam Anxiety

According to Nadia Maloney, Senior Counselling Psychologist and Acting Assistant Director of SCD, “Common test anxiety symptoms include heart palpitations, sweaty palms, difficulty breathing, feeling overwhelmed, irritability, fatigue, and sleeping difficulties. We’re probably in agreement that experiencing any of these symptoms is highly uncomfortable, not conducive to an ideal learning environment, and can affect your exam outcome.”

The 'Taming Test and Exam Anxiety' guide, compiled by Maloney, emphasises the importance of mitigating these symptoms to create an ideal learning environment in order to achieve better exam outcomes.

I Don't Know How to Study

For those who find themselves struggling with study methods, Lize van den Bergh, a Senior Counselling Psychologist, has created the 'I Don't Know How to Study' guide, which underscores the significance of adapting to the university's unique challenges early on, offering valuable tips and techniques to enhance study skills.

Where Is My Time Going?

The 'Where Is My Time Going?' guide, also crafted by Van den Bergh, tackles the issue of time management. It offers practical advice for students who often feel that time is slipping through their fingers due to various commitments and responsibilities. “Study methods consist of many important behaviours and techniques. Because university is different to school, the sooner you learn how to adapt to these changes, the better you will manage,” Van den Bergh said.

As stress and anxiety levels peak around exam time, the importance of studying smart, not just hard, cannot be stressed enough. Students looking for further assistance can reach out to the SCD Office via the provided contact details:

+27 51 401 2853 / SCD@ufs.ac.za (Bloemfontein Campus)
+27 51 505 1989 / SCDSouth@ufs.ac.za (South Campus) 
+27 58 718 5125 / SCDQQ@ufs.ac.za (Qwaqwa Campus)
+27 800 00 6363 / 24/7 Toll-free UFS Student Careline 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept